The Child and Adolescent Thyroid Consortium (CATC) has been designed to create a global community of pediatric investigators dedicated to improving the health of children with thyroid-related conditions.
The CATC Biorepository has been designed to accelerate translational research and precision medicine through collaboration across institutes around the world. By combining efforts, we make meaningful contributions to the field of pediatric thyroid disease.
Retrospective and prospective specimens from member institutions will be sent to the CATC Operations Center at the Children’s Hospital of Philadelphia (CHOP) for storage in the biorepository. Depending on your institutional guidelines, retrospective specimen collection may or may not require patient consent/assent. Prospective specimen collection will be obtained only after consent/assent.
Formalin-fixed paraffin-embedded (FFPE) tissue, flash-frozen tissue, blood, and saliva are used for subsequent cellular, biochemical, and/or genetic analysis to identify driver mutations and differences in target gene expression.
For more information on biospecimen processing, email thyroidresearch@chop.edu.
Below are some types of molecular testing that will be performed. As new technologies continue to become available, the breadth of molecular testing will continue to expand.
Infinium Global Diversity Assay detects copy number alterations.
Infinium EPIC Assay detects methylation at CpG islands based on highly multiplexed genotyping of bisulfate-converted genomic DNA. Methylation analysis provides relevant information regarding the regulation of DNA sections that may go undetected when using sequencing analyses alone.
Spatial transcriptomics provides quantitative gene expression data and visualization of the distribution of mRNAs within tissue sections. Spatial Gene Expression will typically be performed on selected cases.